Literature DB >> 24695702

Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury.

Katalin Bartus1, Nicholas D James, Athanasios Didangelos, Karen D Bosch, Joost Verhaagen, Rafael J Yáñez-Muñoz, John H Rogers, Bernard L Schneider, Elizabeth M Muir, Elizabeth J Bradbury.   

Abstract

Chondroitin sulfate proteoglycans (CSPGs) inhibit repair following spinal cord injury. Here we use mammalian-compatible engineered chondroitinase ABC (ChABC) delivered via lentiviral vector (LV-ChABC) to explore the consequences of large-scale CSPG digestion for spinal cord repair. We demonstrate significantly reduced secondary injury pathology in adult rats following spinal contusion injury and LV-ChABC treatment, with reduced cavitation and enhanced preservation of spinal neurons and axons at 12 weeks postinjury, compared with control (LV-GFP)-treated animals. To understand these neuroprotective effects, we investigated early inflammatory changes following LV-ChABC treatment. Increased expression of the phagocytic macrophage marker CD68 at 3 d postinjury was followed by increased CD206 expression at 2 weeks, indicating that large-scale CSPG digestion can alter macrophage phenotype to favor alternatively activated M2 macrophages. Accordingly, ChABC treatment in vitro induced a significant increase in CD206 expression in unpolarized monocytes stimulated with conditioned medium from spinal-injured tissue explants. LV-ChABC also promoted the remodelling of specific CSPGs as well as enhanced vascularity, which was closely associated with CD206-positive macrophages. Neuroprotective effects of LV-ChABC corresponded with improved sensorimotor function, evident as early as 1 week postinjury, a time point when increased neuronal survival correlated with reduced apoptosis. Improved function was maintained into chronic injury stages, where improved axonal conduction and increased serotonergic innervation were also observed. Thus, we demonstrate that ChABC gene therapy can modulate secondary injury processes, with neuroprotective effects that lead to long-term improved functional outcome and reveal novel mechanistic evidence that modulation of macrophage phenotype may underlie these effects.

Entities:  

Keywords:  chondroitinase; contusion; gene therapy; neuroprotection; spinal cord injury

Mesh:

Substances:

Year:  2014        PMID: 24695702      PMCID: PMC3972714          DOI: 10.1523/JNEUROSCI.4369-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  69 in total

1.  Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury.

Authors:  Farida Hellal; Andres Hurtado; Jörg Ruschel; Kevin C Flynn; Claudia J Laskowski; Martina Umlauf; Lukas C Kapitein; Dinara Strikis; Vance Lemmon; John Bixby; Casper C Hoogenraad; Frank Bradke
Journal:  Science       Date:  2011-01-27       Impact factor: 47.728

2.  Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression.

Authors:  Fernando O Martinez; Siamon Gordon; Massimo Locati; Alberto Mantovani
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

3.  Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.

Authors:  Stéphane Palfi; Jean Marc Gurruchaga; G Scott Ralph; Helene Lepetit; Sonia Lavisse; Philip C Buttery; Colin Watts; James Miskin; Michelle Kelleher; Sarah Deeley; Hirokazu Iwamuro; Jean Pascal Lefaucheur; Claire Thiriez; Gilles Fenelon; Cherry Lucas; Pierre Brugières; Inanna Gabriel; Kou Abhay; Xavier Drouot; Naoki Tani; Aurelie Kas; Bijan Ghaleh; Philippe Le Corvoisier; Patrice Dolphin; David P Breen; Sarah Mason; Natalie Valle Guzman; Nicholas D Mazarakis; Pippa A Radcliffe; Richard Harrop; Susan M Kingsman; Olivier Rascol; Stuart Naylor; Roger A Barker; Philippe Hantraye; Philippe Remy; Pierre Cesaro; Kyriacos A Mitrophanous
Journal:  Lancet       Date:  2014-01-10       Impact factor: 79.321

Review 4.  Degeneration and regeneration of axons in the lesioned spinal cord.

Authors:  M E Schwab; D Bartholdi
Journal:  Physiol Rev       Date:  1996-04       Impact factor: 37.312

5.  A sulfated carbohydrate epitope inhibits axon regeneration after injury.

Authors:  Joshua M Brown; Jiang Xia; BinQuan Zhuang; Kin-Sang Cho; Claude J Rogers; Cristal I Gama; Manish Rawat; Sarah E Tully; Noriko Uetani; Daniel E Mason; Michel L Tremblay; Eric C Peters; Osami Habuchi; Dong F Chen; Linda C Hsieh-Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

6.  Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis.

Authors:  Claudia Monaco; Scott M Gregan; Tina J Navin; Brian M J Foxwell; Alun H Davies; Marc Feldmann
Journal:  Circulation       Date:  2009-12-15       Impact factor: 29.690

7.  Exogenous glycosaminoglycans induce complete inversion of retinal ganglion cell bodies and their axons within the retinal neuroepithelium.

Authors:  P A Brittis; J Silver
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

8.  Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis.

Authors:  Sunhwa Kim; Hiroyuki Takahashi; Wan-Wan Lin; Pascal Descargues; Sergei Grivennikov; Youngjun Kim; Jun-Li Luo; Michael Karin
Journal:  Nature       Date:  2009-01-01       Impact factor: 49.962

9.  Chondroitinase ABC-mediated plasticity of spinal sensory function.

Authors:  William B J Cafferty; Elizabeth J Bradbury; Malcolm Lidierth; Martyn Jones; Philip J Duffy; Sophie Pezet; Stephen B McMahon
Journal:  J Neurosci       Date:  2008-11-12       Impact factor: 6.167

10.  Functional regeneration of respiratory pathways after spinal cord injury.

Authors:  Warren J Alilain; Kevin P Horn; Hongmei Hu; Thomas E Dick; Jerry Silver
Journal:  Nature       Date:  2011-07-13       Impact factor: 49.962

View more
  84 in total

1.  Sugar-dependent modulation of neuronal development, regeneration, and plasticity by chondroitin sulfate proteoglycans.

Authors:  Gregory M Miller; Linda C Hsieh-Wilson
Journal:  Exp Neurol       Date:  2015-08-24       Impact factor: 5.330

2.  Feasible stabilization of chondroitinase abc enables reduced astrogliosis in a chronic model of spinal cord injury.

Authors:  Andrea Raspa; Edoardo Bolla; Claudia Cuscona; Fabrizio Gelain
Journal:  CNS Neurosci Ther       Date:  2018-05-31       Impact factor: 5.243

3.  Plasticity Induced Recovery of Breathing Occurs at Chronic Stages after Cervical Contusion.

Authors:  Philippa Mary Warren; Warren Joseph Alilain
Journal:  J Neurotrauma       Date:  2019-02-19       Impact factor: 5.269

4.  Regulation of IL-10 by chondroitinase ABC promotes a distinct immune response following spinal cord injury.

Authors:  Athanasios Didangelos; Michaela Iberl; Elin Vinsland; Katalin Bartus; Elizabeth J Bradbury
Journal:  J Neurosci       Date:  2014-12-03       Impact factor: 6.167

5.  Plasticity of intact rubral projections mediates spontaneous recovery of function after corticospinal tract injury.

Authors:  Chad S Siegel; Kathren L Fink; Stephen M Strittmatter; William B J Cafferty
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

Review 6.  The influence of microenvironment and extracellular matrix molecules in driving neural stem cell fate within biomaterials.

Authors:  Thomas Wilems; Sangamithra Vardhan; Siliang Wu; Shelly Sakiyama-Elbert
Journal:  Brain Res Bull       Date:  2019-03-18       Impact factor: 4.077

7.  Photobiomodulation Therapy Inhibit the Activation and Secretory of Astrocytes by Altering Macrophage Polarization.

Authors:  Jiakai Sun; Jiawei Zhang; Kun Li; Qiao Zheng; Jiwei Song; Zhuowen Liang; Tan Ding; Lin Qiao; Jianxin Zhang; Xueyu Hu; Zhe Wang
Journal:  Cell Mol Neurobiol       Date:  2019-08-24       Impact factor: 5.046

8.  2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination.

Authors:  Ana Feliú; Itziar Bonilla Del Río; Francisco Javier Carrillo-Salinas; Gloria Hernández-Torres; Leyre Mestre; Nagore Puente; Silvia Ortega-Gutiérrez; Maria L López-Rodríguez; Pedro Grandes; Miriam Mecha; Carmen Guaza
Journal:  J Neurosci       Date:  2017-07-27       Impact factor: 6.167

9.  Combined chondroitinase and KLF7 expression reduce net retraction of sensory and CST axons from sites of spinal injury.

Authors:  Zimei Wang; Kristen Winsor; Christopher Nienhaus; Evan Hess; Murray G Blackmore
Journal:  Neurobiol Dis       Date:  2016-12-14       Impact factor: 5.996

Review 10.  Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury.

Authors:  Christopher S Ahuja; Michael Fehlings
Journal:  Stem Cells Transl Med       Date:  2016-04-29       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.